BIOTECHNOLOGY VALUE FUND L P - Insider Non-Derivative Transactions at Cullinan Therapeutics, Inc. (CGEM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 19, 2023, BIOTECHNOLOGY VALUE FUND L P's relationship to Cullinan Therapeutics, Inc. (CGEM) is Other, and currently has 558,854 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CGEM insiders.
Data Source: SEC.
BIOTECHNOLOGY VALUE FUND L P - Insider Non-Derivative Transactions at CGEM
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 20, 2023 | J -- (Common Stock) | 300000 | 0 | 64161 |
| Jan 20, 2023 | J -- (Common Stock) | 2600000 | 0 | 392808 |
| Jan 20, 2023 | J -- (Common Stock) | 3500000 | 0 | 558854 |